NeoGenomics, Inc. Operating Lease Liability
NeoGenomics, Inc. (NEO) had Operating Lease Liability of $67.60 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-02-17
- 2025-12-31: Operating Lease, Liability $67.60M.
- 2024-12-31: Operating Lease, Liability $64.22M.
- 2023-12-31: Operating Lease, Liability $73.48M.
- 2022-12-31: Operating Lease, Liability $75.54M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $67.60M 10-K · filed 2026-02-17 |
| 2024-12-31 | $64.22M 10-K · filed 2025-02-18 |
| 2023-12-31 | $73.48M 10-K · filed 2024-02-20 |
| 2022-12-31 | $75.54M 10-K · filed 2023-02-24 |
| 2021-12-31 | $79.17M 10-K · filed 2022-02-25 |
| 2021-09-30 | $79.32M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $55.27M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $51.55M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $47.26M 10-K · filed 2021-02-25 |
| 2020-09-30 | $47.82M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $49.02M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $50.41M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $27.41M 10-K · filed 2020-02-28 |
| 2019-09-30 | $27.40M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $27.61M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $20.27M 10-Q · filed 2019-05-08 |
| 2019-01-01 | $10.10M 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |